Table 1

Baseline characteristics of the study cohort and after stratification into two groups based on the presence of CHF

VariableAll patientsWithout CHFWith CHF
Number of patients172 199117 23854 961
Age, years62.1 ± 14.860.9 ± 15.264.8 ± 13.6
Gender, male, %55.155.853.7
Race, White, %61.661.062.8
Diabetic, %64.261.470.2
CHF, %31.9N/AN/A
Central venous catheter as vascular access, %29.929.231.2
Pre-dialysis SBP, mmHg149.6 ± 19.3150.0 ± 18.8148.7 ± 20.3
Post-dialysis SBP, mmHg139.6 ± 17.2139.7 ± 16.9139.3 ± 17.6
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg−10.0 ± 13.9−10.4 ± 13.8−9.4 ± 14.2
UFR, mL/kg/h9.1 ± 3.39.0 ± 3.39.4 ± 3.3
Body mass index, kg/m228.3 ± 7.628.2 ± 7.528.7 ± 7.8
Interdialytic weight change, percentage of post-HD weight3.3 ± 1.23.3 ± 1.23.4 ± 1.2
Serum albumin, g/dL3.7 ± 0.43.7 ± 0.43.7 ± 0.4
enPCR, g/kg/day0.9 ± 0.20.9 ± 0.20.9 ± 0.2
VariableAll patientsWithout CHFWith CHF
Number of patients172 199117 23854 961
Age, years62.1 ± 14.860.9 ± 15.264.8 ± 13.6
Gender, male, %55.155.853.7
Race, White, %61.661.062.8
Diabetic, %64.261.470.2
CHF, %31.9N/AN/A
Central venous catheter as vascular access, %29.929.231.2
Pre-dialysis SBP, mmHg149.6 ± 19.3150.0 ± 18.8148.7 ± 20.3
Post-dialysis SBP, mmHg139.6 ± 17.2139.7 ± 16.9139.3 ± 17.6
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg−10.0 ± 13.9−10.4 ± 13.8−9.4 ± 14.2
UFR, mL/kg/h9.1 ± 3.39.0 ± 3.39.4 ± 3.3
Body mass index, kg/m228.3 ± 7.628.2 ± 7.528.7 ± 7.8
Interdialytic weight change, percentage of post-HD weight3.3 ± 1.23.3 ± 1.23.4 ± 1.2
Serum albumin, g/dL3.7 ± 0.43.7 ± 0.43.7 ± 0.4
enPCR, g/kg/day0.9 ± 0.20.9 ± 0.20.9 ± 0.2

Data are expressed as mean ± SD or percentage.

enPCR, equilibrated normalized protein catabolic rate; N/A, not applicable.

Table 1

Baseline characteristics of the study cohort and after stratification into two groups based on the presence of CHF

VariableAll patientsWithout CHFWith CHF
Number of patients172 199117 23854 961
Age, years62.1 ± 14.860.9 ± 15.264.8 ± 13.6
Gender, male, %55.155.853.7
Race, White, %61.661.062.8
Diabetic, %64.261.470.2
CHF, %31.9N/AN/A
Central venous catheter as vascular access, %29.929.231.2
Pre-dialysis SBP, mmHg149.6 ± 19.3150.0 ± 18.8148.7 ± 20.3
Post-dialysis SBP, mmHg139.6 ± 17.2139.7 ± 16.9139.3 ± 17.6
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg−10.0 ± 13.9−10.4 ± 13.8−9.4 ± 14.2
UFR, mL/kg/h9.1 ± 3.39.0 ± 3.39.4 ± 3.3
Body mass index, kg/m228.3 ± 7.628.2 ± 7.528.7 ± 7.8
Interdialytic weight change, percentage of post-HD weight3.3 ± 1.23.3 ± 1.23.4 ± 1.2
Serum albumin, g/dL3.7 ± 0.43.7 ± 0.43.7 ± 0.4
enPCR, g/kg/day0.9 ± 0.20.9 ± 0.20.9 ± 0.2
VariableAll patientsWithout CHFWith CHF
Number of patients172 199117 23854 961
Age, years62.1 ± 14.860.9 ± 15.264.8 ± 13.6
Gender, male, %55.155.853.7
Race, White, %61.661.062.8
Diabetic, %64.261.470.2
CHF, %31.9N/AN/A
Central venous catheter as vascular access, %29.929.231.2
Pre-dialysis SBP, mmHg149.6 ± 19.3150.0 ± 18.8148.7 ± 20.3
Post-dialysis SBP, mmHg139.6 ± 17.2139.7 ± 16.9139.3 ± 17.6
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg−10.0 ± 13.9−10.4 ± 13.8−9.4 ± 14.2
UFR, mL/kg/h9.1 ± 3.39.0 ± 3.39.4 ± 3.3
Body mass index, kg/m228.3 ± 7.628.2 ± 7.528.7 ± 7.8
Interdialytic weight change, percentage of post-HD weight3.3 ± 1.23.3 ± 1.23.4 ± 1.2
Serum albumin, g/dL3.7 ± 0.43.7 ± 0.43.7 ± 0.4
enPCR, g/kg/day0.9 ± 0.20.9 ± 0.20.9 ± 0.2

Data are expressed as mean ± SD or percentage.

enPCR, equilibrated normalized protein catabolic rate; N/A, not applicable.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close